It has been acknowledged that the progression of CKD is related to various clinical risk factors such as hypertension, hyperlipidemia, insulin resistance, systemic inflammation thrombotic factors, vascular endothelial growth factor and systemic endothelial dysfunction15–17, although which needs to be further confirmed. Here, VEGFA is linked to hypertensive disorder.